cladribine has been researched along with Mast Cell Activation Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amazzough, K; Barete, S; Canioni, D; Casassus, P; Chandesris, MO; Coignard-Biehler, H; Damaj, G; Dubreuil, P; Durieu, I; Elie, C; Fraitag, S; Georgin-Lavialle, S; Grosbois, B; Guillet, G; Gyan, E; Hamidou, M; Hermine, O; Hirsch, I; Kahn, JE; Larroche, C; Lhermitte, L; Limal, N; Lortholary, O; Suarez, F | 1 |
| Akin, C | 1 |
| Mick, AB | 1 |
| Amon, U; Hartmann, K; Horny, HP; Nowak, A | 1 |
| Escribano, L; Núñez, R; Orfao, A; Pérez de Oteyza, J | 1 |
| Nieva, J; Saven, A | 1 |
| Butterfield, JH; Hoffbrand, AV; Pardanani, A; Tefferi, A | 1 |
| Pardanani, A; Tefferi, A | 1 |
| Butterfield, JH; Hoagland, HC; Li, CY; Tefferi, A | 1 |
3 review(s) available for cladribine and Mast Cell Activation Disease
| Article | Year |
|---|---|
Mastocytosis - an update.
Topics: Adult; Antineoplastic Agents; Biopsy; Child; Chronic Disease; Cladribine; Codon; Diagnosis, Differential; DNA Mutational Analysis; Exons; Humans; Immunologic Factors; Infant; Interferon-alpha; Mast Cells; Mastocytosis; Proto-Oncogene Proteins c-kit; Skin | 2010 |
Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biology.
Topics: Antineoplastic Agents; Child; Cladribine; Humans; Leukocytes; Mastocytosis; Retreatment | 2004 |
Clinical, genetic, and therapeutic insights into systemic mast cell disease.
Topics: Adult; Benzamides; Cladribine; Humans; Imatinib Mesylate; Mast Cells; Mastocytosis; Mastocytosis, Systemic; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2004 |
6 other study(ies) available for cladribine and Mast Cell Activation Disease
| Article | Year |
|---|---|
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Mastocytosis; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Cladribine for mastocytosis: benefits and risks.
Topics: Antineoplastic Agents; Cladribine; Female; Humans; Male; Mastocytosis | 2015 |
Clinical Pearls.
Topics: Adolescent; Adult; Cladribine; Contact Lenses; Diplopia; Exophthalmos; Eye Diseases; Eyelid Diseases; Goldenhar Syndrome; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mastocytosis; Middle Aged | 2016 |
Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma.
Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mast Cells; Mastocytosis | 2002 |
Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine.
Topics: Adult; Aged; Bone Marrow Examination; Cladribine; Disease-Free Survival; Drug Administration Schedule; Drug Resistance; Female; Humans; Interferon-alpha; Male; Mastocytosis; Middle Aged; Remission Induction; Treatment Outcome | 2004 |
Treatment of systemic mast-cell disease with cladribine.
Topics: Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Male; Mastocytosis; Middle Aged | 2001 |